Detecting Critical Congenital Heart Disease in Nevada.


Journal

World journal for pediatric & congenital heart surgery
ISSN: 2150-136X
Titre abrégé: World J Pediatr Congenit Heart Surg
Pays: United States
ID NLM: 101518415

Informations de publication

Date de publication:
11 2019
Historique:
entrez: 9 11 2019
pubmed: 9 11 2019
medline: 15 8 2020
Statut: ppublish

Résumé

We reviewed data on patients born with critical congenital heart disease in the state of Nevada and analyzed detection via prenatal diagnosis versus newborn pulse oximetry screening, location of birth, and gestational age at birth. We inquired our databases and electronic health records for all patients with critical congenital heart disease born in Nevada between January 2016 and May 2019. We identified 218 live born patients. Of the 218, average gestational age was 38 weeks (±2.2 weeks). Of the 218, 171 (78%) were prenatally diagnosed, 37 (17%) were diagnosed by immediate postnatal signs and symptoms, 8 (4%) had false-negative pulse oximetry screens that resulted in post-hospital discharge presentations, and 2 (1%) had positive pulse oximetry screens. The eight post-hospital discharge presentations included four in extremis, two with extreme cyanosis, and two dying at home. Of the 171 prenatally diagnosed patients, 157 (92%) were born at the Nevada hospital with the congenital cardiac unit. To the best of our knowledge, our results represent the highest statewide, general population prenatal detection of critical congenital heart disease in the United States. Our high prenatal detection rate led to the majority of patients being born at the Nevada facility with the congenital heart unit, limiting intrastate neonatal transports. On average, patients were born at term. Further, in Nevada, state-mandated, universal pulse oximetry screening resulted in more false-negative results than positive results.

Sections du résumé

BACKGROUND
We reviewed data on patients born with critical congenital heart disease in the state of Nevada and analyzed detection via prenatal diagnosis versus newborn pulse oximetry screening, location of birth, and gestational age at birth.
METHODS
We inquired our databases and electronic health records for all patients with critical congenital heart disease born in Nevada between January 2016 and May 2019.
RESULTS
We identified 218 live born patients. Of the 218, average gestational age was 38 weeks (±2.2 weeks). Of the 218, 171 (78%) were prenatally diagnosed, 37 (17%) were diagnosed by immediate postnatal signs and symptoms, 8 (4%) had false-negative pulse oximetry screens that resulted in post-hospital discharge presentations, and 2 (1%) had positive pulse oximetry screens. The eight post-hospital discharge presentations included four in extremis, two with extreme cyanosis, and two dying at home. Of the 171 prenatally diagnosed patients, 157 (92%) were born at the Nevada hospital with the congenital cardiac unit.
CONCLUSION
To the best of our knowledge, our results represent the highest statewide, general population prenatal detection of critical congenital heart disease in the United States. Our high prenatal detection rate led to the majority of patients being born at the Nevada facility with the congenital heart unit, limiting intrastate neonatal transports. On average, patients were born at term. Further, in Nevada, state-mandated, universal pulse oximetry screening resulted in more false-negative results than positive results.

Identifiants

pubmed: 31701835
doi: 10.1177/2150135119873847
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

702-706

Commentaires et corrections

Type : CommentIn

Auteurs

William N Evans (WN)

Children's Heart Center Nevada, Las Vegas, NV, USA.
Division of Pediatric Cardiology, Department of Pediatrics, University of Nevada, Las Vegas School of Medicine, NV, USA.

Ruben J Acherman (RJ)

Children's Heart Center Nevada, Las Vegas, NV, USA.
Division of Pediatric Cardiology, Department of Pediatrics, University of Nevada, Las Vegas School of Medicine, NV, USA.

Michael L Ciccolo (ML)

Children's Heart Center Nevada, Las Vegas, NV, USA.
Department of Surgery, University of Nevada, Las Vegas School of Medicine, NV, USA.

Juan Lehoux (J)

Children's Heart Center Nevada, Las Vegas, NV, USA.

Abraham Rothman (A)

Children's Heart Center Nevada, Las Vegas, NV, USA.
Division of Pediatric Cardiology, Department of Pediatrics, University of Nevada, Las Vegas School of Medicine, NV, USA.

Alvarao Galindo (A)

Children's Heart Center Nevada, Las Vegas, NV, USA.
Division of Pediatric Cardiology, Department of Pediatrics, University of Nevada, Las Vegas School of Medicine, NV, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH